Mastering the Clinical Development of Personalized Cancer Medicines
A string of innovative clinical trials designed to accelerate the pace at which personalized cancer medicines are developed have...
Category: Research
A string of innovative clinical trials designed to accelerate the pace at which personalized cancer medicines are developed have...
The rapid fire of U.S. Food and Drug Administration (FDA) approvals of new treatments for cancer continued last week...
A recent study in the AACR’s journal Cancer Epidemiology, Biomarkers & Prevention suggests that different types of cancer fear...
Big progress was made in 2014, in the form of FDA approvals for new immunotherapies, targeted therapies, and a...
With the late-breaking and clinical trial-placeholder abstract deadlines a week away, we thought it was a good time to...
A major question that researchers are trying to answer is: What links obesity with cancer development and adverse survival?
Cancer immunotherapy, which entered 2014 with the accolade of Science magazine’s Breakthrough of the Year for 2013, ended the...
As 2014 draws to a close, we look back on an exciting year during which we provided more than...
Nina Bhardwaj, MD, PhD, co-chair of the AACR's special conference "Tumor Immunology and Immunotherapy: A New Chapter," discusses what...
Despite current screening efforts, colorectal cancer is the fourth most commonly diagnosed cancer worldwide and the fifth leading cause...